Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 20, 2024 (3 years ago)

Moxifloxacin PF

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injection, Intracameral Use Only, Single- Dose Vial, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-096-42

Affected NDC 71449-0096-42

Compare with the code on your package — it is the most precise check available.

Drug: Moxifloxacin

Recalling firm
Denver Solutions, LLC DBA Leiters Health
NDC code
71449-096-42
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0361-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Moxifloxacin recalls

See all

Other recalls by Denver Solutions, LLC DBA Leiters Health

All 2024 recalls